| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/26/2005 | CA2503095A1 Use of lif in cell and tissue engineering |
| 11/24/2005 | WO2005111208A1 Method of proliferating plasma cell |
| 11/24/2005 | WO2005111200A1 Novel strains of reoviruses and methods of uses thereof |
| 11/24/2005 | WO2005111195A2 Improved prebiotic |
| 11/24/2005 | WO2005111194A1 Self-containing lactobacillus strain |
| 11/24/2005 | WO2005110445A2 Methods and compositions for the dietary management of autoimmune disorders |
| 11/24/2005 | WO2005087931A8 Modified oncolytic viruses |
| 11/24/2005 | WO2005065354A3 Defined media for pluripotent stem cell culture |
| 11/24/2005 | WO2005063200A3 Probiotic tablet formulations |
| 11/24/2005 | WO2005060498A3 Composition and method for inhibiting salmonella and campylobacter colonization in poultry |
| 11/24/2005 | WO2005052145A3 Recombinant alkaliizing bacteria |
| 11/24/2005 | WO2005049077A3 Avian vaccine effective against infectious bursal disease virus |
| 11/24/2005 | WO2005034971A3 Antiviral agent |
| 11/24/2005 | WO2005017131A3 Methods for the differentiation of human stem cells |
| 11/24/2005 | WO2005002499A3 A method and therapeutic platelets |
| 11/24/2005 | WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations |
| 11/24/2005 | WO2004060303A3 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 11/24/2005 | US20050261326 Metabolites of ecteinascidin 743 |
| 11/24/2005 | US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050260753 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 11/24/2005 | US20050260751 Pluripotent adult stem cells |
| 11/24/2005 | US20050260750 Process for obtaining mammalian insulin secreting cells in vitro and their uses |
| 11/24/2005 | US20050260748 Adult stem cells and uses thereof |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260623 Oct-4 and GJIC expression as markers for adult human stem cells and cancer cell precursors |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260560 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 11/24/2005 | US20050260293 Biocontrol for plants with bacillus subtilis, pseudomonas putida, and sporobolomyces roseus |
| 11/24/2005 | US20050260283 Composition for prevention and treatment of colon adenomas |
| 11/24/2005 | US20050260282 Novel hypoglycemic agent, diabetes preventive agent, deep sea water concentrate, and method for producing deep sea water concentrate |
| 11/24/2005 | US20050260227 Novel therapeutic processes for treating cancer with specific antigens |
| 11/24/2005 | US20050260226 Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260178 Delivery of an organized tissue to an organism |
| 11/24/2005 | US20050260176 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 11/24/2005 | US20050260175 Therapy for cardiovascular disorders; automatic system; separation of stem cell, progenitor cells from adipose tissue; concentration |
| 11/24/2005 | US20050260174 Systems and methods for treating patients with processed lipoaspirate cells |
| 11/24/2005 | US20050260172 Culture of goblet cells |
| 11/24/2005 | US20050260171 Compositions containing bacteriophages and method of using bacteriophages to treat infections |
| 11/24/2005 | US20050260170 Bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| 11/24/2005 | US20050260169 Treatment of cancer using HSV mutant |
| 11/24/2005 | US20050260162 Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | DE202005012984U1 Oral combination, useful in the treatment and/or prophylaxis of eye diseases e.g. glaucoma, comprises one or more dosage units comprising e.g. zinc oxide; highly purified fish oil; ascorbic acid and optionally carotenoid, cinnamon |
| 11/24/2005 | DE102004028302B4 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 11/24/2005 | DE102004020762A1 Preparation of an oncolytic virus suspension, useful for treating cancers, comprises inoculating tumor cell lines with viruses and selecting oncolytic viruses in the culture supernatant that can form syncitia |
| 11/24/2005 | CA2567106A1 Self-containing lactobacillus strain |
| 11/24/2005 | CA2566517A1 Improved konjac glucomannan cellulase hydrolysate prebiotics |
| 11/24/2005 | CA2566415A1 Methods and compositions for the dietary management of autoimmune disorders |
| 11/24/2005 | CA2565070A1 Anti-ctgf agents for the treatment of pancreatic cancer |
| 11/23/2005 | EP1598417A1 Anterior ocular segment related cell sheet, three-dimensional structures and process for producing the same |
| 11/23/2005 | EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle |
| 11/23/2005 | EP1597354A2 System for external control of oncolytic virus replication |
| 11/23/2005 | EP1596872A1 Compositions and methods for restoring bacterial flora |
| 11/23/2005 | EP1596871A2 T cell regulation |
| 11/23/2005 | EP1596659A2 Progenitor cells and methods of using same |
| 11/23/2005 | EP1578459A3 Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| 11/23/2005 | EP1507848A4 Expansion and transdifferentiation of human acinar cells |
| 11/23/2005 | EP1446015A4 Remodeling of tissues and organs |
| 11/23/2005 | EP1401495A4 T cell induced tissue repair and regeneration |
| 11/23/2005 | EP1383872B1 Genetically modified yt cell line and use thereof |
| 11/23/2005 | EP1292249B1 Tissue engineered stents |
| 11/23/2005 | EP1185628B1 Isolation of a human retrovirus |
| 11/23/2005 | EP1140291B1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor |
| 11/23/2005 | EP1133555B1 Pharmaceutical factor vii preparation |
| 11/23/2005 | EP1117767B1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 11/23/2005 | EP1025850B1 Isoflavone-containing compositions |
| 11/23/2005 | EP1007060B1 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
| 11/23/2005 | EP0952773B1 Methods and compositions for prevention and treatment of clostridium difficile-associated diseases |
| 11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
| 11/23/2005 | EP0770129B1 Zinc finger protein derivatives and methods therefor |
| 11/23/2005 | CN1701116A Probiotic bacterium: lactobacillus fermentum |
| 11/23/2005 | CN1700926A Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition |
| 11/23/2005 | CN1700925A Plasmid-free clone of E. coli strain DSM 6601 |
| 11/23/2005 | CN1699581A Tumor target gene-virus ZD55-IL-24, construction method and application thereof |
| 11/23/2005 | CN1698660A Composite immunopotentiator used for flounder baby fish |
| 11/23/2005 | CN1698659A Preparation of oral local applied paster and application thereof |
| 11/23/2005 | CN1698658A Composite propolis soft capsule |
| 11/23/2005 | CN1698657A Technique for preparing thinly stratified pearl powder by instant explosion method |
| 11/23/2005 | CN1698656A Medicine for wound healing and preparation method thereof |
| 11/23/2005 | CN1698655A Ossotide injection and preparation method thereof |
| 11/23/2005 | CN1698654A Internal remedy for treating hemorrhoids and preparation method thereof |
| 11/23/2005 | CN1698653A Injection of calf blood de-protein extract and preparation method thereof |
| 11/23/2005 | CN1698652A Method for extracting matter with irritation cell respiratory activity from pig blood |
| 11/23/2005 | CN1698651A Chilblain preventing and curing cream containing nutria fat |
| 11/23/2005 | CN1698648A Montmorillonite dispersed tablet and preparation technique thereof |
| 11/23/2005 | CN1228443C Hematopoietic differentiation of human embryonic stem cells |
| 11/23/2005 | CN1228095C Method for eliminating antigen from animal fur |
| 11/23/2005 | CN1228082C Method for preparing pharmaceutics of hydrolysate of brain protein |
| 11/23/2005 | CN1228058C Production method of medical healthcare beautifying product |
| 11/23/2005 | CN1228057C Compound of solanesol and its preparing process |
| 11/23/2005 | CN1228056C Powder for trauma |
| 11/23/2005 | CN1228055C Multi-function medicine for beautifying and treating scald by boiled water or fire and cold injury |
| 11/23/2005 | CN1228050C Medicine for preventing tissue from adhesion after operation |
| 11/22/2005 | US6967239 obtaining a starting factor VIII solution comprising factor VIII-von Willebrand factor complexes; and filtering in presence of calcium chloride ions through hydrophilic virus filter having a mean pore size of 13 to 17 nm |
| 11/22/2005 | US6967100 Propagating islet of langerhans cells; obtain cells, culture in presence of bone morphogenic protein or modulator, monitor proliferation of cells |
| 11/22/2005 | US6967025 A disposable product comprising an absorbent core containing atleast a spore which has the ability to germinate into a microorganism which is antagonist of undesirable strains of microorgansims |